Gum repair breakthrough? new combo treatment shows promise for Tooth-Saving surgery

NCT ID NCT07042204

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested whether using a patient's own blood concentrate (ePRF) alone or mixed with bioactive glass nanoparticles can help repair bone defects in gum disease. Thirty adults with grade II furcation defects (bone loss between tooth roots) received one of three surgical treatments. The main goal was to measure bone fill using 3D X-rays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
extended platelet-rich fibrin (ePRF) and bioactive glass nanoparticles
What this could lead to
If successful, this could point toward a better way to repair bone loss in gum disease, potentially improving tooth retention.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply widely. The treatments are surgical procedures, and outcomes depend on individual healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FURCATION DEFECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Furcation Defects

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mansoura University

    Al Mansurah, 35516, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.